Mordor Intelligence, LLP. Launches its Intelligence Center to Help Enterprises Involved in the Business of Diabetes Care Drugs, Make Smarter Decisions, Real Time

India - English

• USA - English

HYDERABAD, India, September 27, 2018 /PRNewswire/ --

Mordor Intelligence today announced the launch of its Intelligence Center on the Diabetes Care Drugs Market. The platform at its core is a web of data points meticulously curated to help enterprises of all sizes in the domain of Diabetes Care Drugs. Such information is available at present only sporadically and is mainly geared towards bigger players in the industry. With the launch of this Intelligence Center, Mordor Intelligence aims to bridge the gap of available information for the industry.

     (Logo: https://mma.prnewswire.com/media/715894/MORDOR_Intelligence_Logo.jpg )

Speaking to the press on the occasion of the launch, Bharadwaj Reddy, CEO of Mordor Intelligence, said, "Over the years we've observed the need for a platform that offers an exhaustive coverage of various markets in the Healthcare space. Our Diabetes Care Drugs IC positions itself as a cornerstone for organizations in this space - no matter how big, or small. A key takeaway for subscribers of our Intelligence Center is the agility it offers them in setting direction in addition to, taking and executing strategic decisions."

Mordor's Intelligence Center on the Diabetes Care Drugs Market is a one-stop shop offering data spanning 15 segments under 4 categories and covering 25 counties from 5 regions and is backed by brand share information of 33 brands with an R&D pipeline. A key differentiator of this platform in comparison to similar services is the accuracy and timeliness of the data. This Intelligence Center is updated every quarter with significant changes reflecting real-time information. In addition, the platform is extremely user friendly and offers a seamless, intuitive experience. The company is offering a free trial account set up to organizations and individuals to allow them to easily explore the Intelligence Center. This limited time Free Trial can be set up here: https://www.mordorintelligence.com/free-trial/diabetes-care-drugs

The coverage offered is as listed:

Categories & Segments:

1. Insulin 
   1. Basal Insulin
   2. Bolus Insulin
   3. Human Insulin
   4. Human Insulin Inhaled
2. Non-Insulin Injectables 
   1. Amylin Analogue
   2. GLP-1 Agonist
3. Oral Antidiabetic Drugs 
   1. Alpha - Glucosidase inhibitors
   2. Biguanides
   3. Dopamine -D2 receptor agonist
   4. DPP-4 Inhibitors
   5. Meglitinide
   6. SGLT-2 Inhibitors
   7. Sulfonylureas
4. Combination Drugs
   1. Insulin Combination
   2. Oral combination

Regions & Countries: 

- Asia Pacific 

 Australia

 China

 India

 Indonesia

 Japan

 Malaysia

 Philippines

 South Korea

 Thailand

 Vietnam

- Europe

 France

 Germany

 Italy

 Russia

 Spain

 United Kingdom

- North America

 Canada

 United States

- Latin America

 Brazil

 Mexico

- Middle East 

 Egypt

 Iran

 Oman

 Saudi Arabia

 South Africa

Brands:

1. Afrezza 

2. Apidra

3. Basaglar

4. Bydureon

5. Byetta

6. Cycloset

7. Farxiga/Forxiga

8. Galvus

9. Generic

10. Humalog

11. Humulin

12. Insuman

13. Invokana

14. Janumet

15. Januvia

16. Jardiance

17. Lantus

18. Levemir

19. Lyxumia

20. Novolin/Human insulin

21. Novolog/NovoRapid

22. NovoMix

23. Onglyza

24. Ryzodeg

25. Suglat

26. Symlin

27. Toujeo

28. Tradjenta

29. Tresiba

30. Trulicity

31. Victoza

32. Vipidia/Nesina

33. Xultophy

Mordor Intelligence, LLP. operates in the business of industry analysis & consulting, helping clients shape their strategic decisions. Founded in 2013, and fully revenue-funded, Mordor is based out of Hyderabad, India. The company offers custom market intelligence and advisory services along with syndicated reports to help customers gain edge over competition. Mordor caters to over 500 clients across the globe in various industries.

Media Contact:
Name: Sameeksha Bansal
Email: [email protected]
Phone: +1-617-765-2493